Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1524-4725.2012.02492.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sex-specific impacts of caffeine on body composition: commentary on a retrospective cohort study.
J Int Soc Sports Nutr
December 2025
University of Bologna-Alma Mater Studiorum, Department of Quality of Life Sciences, Bologna, Italy.
Background: Understanding the impact of caffeine intake on body composition is a topic of growing research interest. The article "Association Between Caffeine Intake and Fat-Free Mass Index: A Retrospective Cohort Study" by Tian et al. explored this relationship, highlighting a positive correlation between caffeine consumption and fat-free mass index (FFMI).
View Article and Find Full Text PDFT1 Gadolinium-Enhanced Magnetic Resonance Imaging of Glioblastoma: What You See Is Not What You Get.
Int J Radiat Oncol Biol Phys
February 2025
Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida. Electronic address:
Enhancing mental health services in higher education through digital technology.
J Affect Disord
January 2025
School of Education, Tianjin University, Tianjin, PR China.
Bosutinib for the Treatment of CML-Using it Safely: a Podcast.
Target Oncol
January 2025
Division of Hematology and SCT, Georgia Cancer Centre, Augusta, GA, USA.
Bosutinib is a second-generation tyrosine kinase inhibitor (TKI) approved for use in patients with newly diagnosed Philadelphia chromosome (Ph)-positive chronic phase (CP) chronic myeloid leukemia (CML), as well as Ph-positive CP, accelerated phase, or blast phase (with chemotherapy) CML resistant or intolerant to prior therapy. Clinical trials have shown bosutinib is effective as first-line therapy for patients with CML as well as in later lines of therapy after prior TKI failure. Bosutinib has an established safety profile; however, as with all TKIs approved for the treatment of CML, there are adverse events (AEs) that require management.
View Article and Find Full Text PDFEnhancing Resilience in Adolescents With Chronic Medical Illnesses Through Patient-Centered Care: A Call to Action on Thriving and not Only Surviving.
J Adolesc Health
February 2025
Harvard Medical School, Boston, Massachusetts; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!